胺碘酮与普罗帕酮治疗阵发性室上性心动过速的临床分析  

Clinical Research of Amiodarone and Propafenone in the Treatment of Paroxysmal Superventricular Tachycardia

作　　者：李冬华[1] 李波[1] 

机构地区：[1]广东省吴川市人民医院,广东吴川524500

出　　处：《临床医学工程》2013年第3期332-333,共2页Clinical Medicine & Engineering

摘　　要：目的分析胺碘酮与普罗帕酮治疗阵发性室上性心动过速(PSVT)的临床疗效。方法将86例PSVT的患者,随机分为胺碘酮组(43例)和普罗帕酮组(43例),分别选用胺碘酮和普罗帕酮治疗PSVT,比较胺碘酮组和普罗帕酮组两组的临床疗效。结果胺碘酮组的总有效率为90.7%,普罗帕酮组的总有效率为86.0%,两组的总有效率差异无统计学意义(P>0.05)。结论胺碘酮与普罗帕酮治疗PSVT,均能取得比较好的临床疗效,但胺碘酮治疗PSVT疗效更显著。Objective To explore the clinical efficacy of amiodarone and propafenone in the treatment of patients with paroxysmal superventricular tachycardia （PSVT）. Methods 86 patients with PSVT were randomly divided into amiodarone group （43 cases） and propafenone group （43 cases ）. The patients with paroxysmal superventricular tachycardia in amiodarone group and propafenone group were treated with amiodarone and propafenone respectively. The clinical effect was compared between the two groups. Results The total effective rate in amiodarone group and propafenone group was 90.7% and 86.0% respectively, with no significant difference between two groups （P 〉0.05）. Conclusions Amiodarone or propafenone has good clinical efficacy in the treatment of paroxysmal superventricular tachycardia, but amiodarone has more significant efficacy than propafenone.

关 键 词：胺碘酮 普罗帕酮 PSVT 疗效 

分 类 号：R541.71[医药卫生—心血管疾病]